Nothing Special   »   [go: up one dir, main page]

FUKUSHIMA et al., 1995 - Google Patents

Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam

FUKUSHIMA et al., 1995

View PDF
Document ID
1482226986235263003
Author
FUKUSHIMA Y
TAKAHASHI H
HALL W
NAKASONE T
NAKATA S
SONG P
DUC D
HIEN B
QUANG N
TRINH T
NISHIOKA K
KITAMURA K
KOMURO K
VAHLNE A
HONDA M
Publication year
Publication venue
AIDS research and human retroviruses

External Links

Snippet

Serum specimens (n= 1899) were assayed for infections with HTLV-I, HTLV-II, and HIV-1 in seven classified groups of normal healthy controls, children, pregnant women, prostitutes, intravenous drug abusers, patients under going hemodialysis, and hemophiliacs in South …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988AIDS or HTLV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV

Similar Documents

Publication Publication Date Title
FUKUSHIMA et al. Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam
Barin et al. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients
Tedder et al. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS
Lillehoj et al. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide
Couroucé et al. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France
Wiktor et al. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire
Cartier et al. Southernmost carriers of HTLV‐I/II in the world
Anderson et al. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons
Hartley et al. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays
US6242174B1 (en) Discrimination between antibodies against HTLV-I, HTLV-II or related retroviruses, new peptides, detection of antibodies and immunoassay kits
Centers For Disease Control and Prevention and the USPHS Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II)
Brodine et al. Simultaneous confirmation and differentiation of human T‐lymphotropic virus types I and II infection by modified Western blot containing recombinant envelope glycoproteins
Zanetti et al. HTLV-II among Italian intravenous drug users and hemophiliacs
Medrano et al. Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk
Lal et al. Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II
Lal et al. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II
LEE et al. Seroepidemiology of human T-cell leukemia virus type-I in the Republic of Korea
Cardoso et al. Seroprevalence of HTLV‐I in portugal and evidence of double retrovirus infection of a healthy donor
WO1992004046A1 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
Rudolph et al. Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins
De Rivera et al. Geographical clustering of human T-cell lymphotropic virus type 1 infection in Honduras
Schüpbach et al. HTLV‐1 in Switzerland: Low prevalence of specific antibodies in HIV risk groups, high prevalence of cross‐reactive antibodies in normal blood donors
Blomberg et al. Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors
Al-Mufti et al. Seroprevalence of human T-cell leukemia/lymphoma virus type I and type II (HTLV-I/HTLV-II) infection among volunteer blood donors in Kuwait
WO1993002102A1 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same